English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Synthetic μO-conotoxin MrVIB blocks TTX-resistant sodium channel Na(V)1.8 and has a long-lasting analgesic activity

MPS-Authors
/persons/resource/persons15918

Terlau,  Heinrich
Molecular and cellular neuropharmacology, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Bulaj, G., Zhang, M.-M., Green, B. R., Fiedler, B., Layer, R. T., Wei, S., et al. (2006). Synthetic μO-conotoxin MrVIB blocks TTX-resistant sodium channel Na(V)1.8 and has a long-lasting analgesic activity. Biochemistry, 45(23), 7404-7414.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-24DA-8
Abstract
mu O-Conotoxin MrVIB is a blocker of voltage-gated sodium channels, including TTX-sensitive and -resistant subtypes. A comprehensive characterization of this peptide has been hampered by the lack of sufficient synthetic material. Here, we describe the successful chemical synthesis and oxidative folding of MrVIB that has made an investigation of the pharmacological properties and therapeutic potential of the peptide feasible. We show for the first time that synthetic MrVIB blocks rat Na(V)1.8 sodium channels and has potent and long-lasting local anesthetic effects when tested in two pain assays in rats. Furthermore, MrVIB can block propagation of action potentials in A- and C-fibers in sciatic nerve as well as skeletal muscle in isolated preparations from rat. Our work provides the first example of analgesia produced by a conotoxin that blocks sodium channels. The emerging diversity of antinociceptive mechanisms targeted by different classes of conotoxins is discussed.